Indication

Ductal carcinoma in situ of breast

Ductal carcinoma in situ of the breast is a non-invasive, pre-invasive neoplastic proliferation of epithelial cells originating within the breast’s ductal-lobular system. Read more about Ductal carcinoma in situ of breast

16 drugs 16 manufacturers

Advertisement

Drugs that treat it

Common Ductal carcinoma in situ of breast therapies.

Showing 10–16 of 16 drugs

TAMOXIFEN CITRATE

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
A-S MEDICATION

TAMOXIFEN CITRATE

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
DR.REDDY'S LAB

TAMOXIFEN CITRATE

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
PROFICIENT RX L

TAMOXIFEN CITRATE

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
BRYANT RANCH PR

TAMOXIFEN CITRATE

ANTIESTROGEN·PREVENTION OF BREAST CANCER IN HIGH RISK WOMEN·+2
AUROBINDO PHARM
Filter & compare in the drug finder →Opens the drug finder with Ductal carcinoma in situ of breast preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ductal carcinoma in situ of breast.

Ductal carcinoma in situ of the breast is a non-invasive, pre-invasive neoplastic proliferation of epithelial cells originating within the breast’s ductal-lobular system.

The defining hallmark is the malignant transformation of cells lining the milk ducts without penetration through the basement membrane into the surrounding mammary stroma, lymphatic channels, or blood vessels.

Pathophysiologically categorized as stage 0 breast cancer, it predominantly affects adult women and represents a potential, non-obligate precursor to invasive ductal carcinoma.

Although usually asymptomatic and most often identified by characteristic microcalcifications on screening mammography, the lesion is biologically heterogeneous with variable nuclear grade, architectural patterns, and hormone receptor expression.

Personalize your experience

Follow Ductal carcinoma in situ of breast and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it